Iron Polymaltose Complex

Iron Polymaltose Complex is available as powder, DC Grade and injectable grade. It is a medication for treating iron deficiency / iron deficiency anemia.

Request Quote

Molecular Formula – C24H44FeO25

Molecular Weight – 788.4 gm/mol

CAS No – 9007-72-1

Shelf Life – 36 months

HSN Code –  2821.1020

Packing Size – 20 kg in HDPE drum

Storage Condition – Keep Well Closed, protected against light, dry and at room temperature

Additional Info – 1. Available as powder, DC grade & injectable grade

2. Wide range of elemental iron content (30% – 38% w/w)

3. Outstanding microbial profile

1. Description Brown to deep brown colored granules.
2. Solubility Soluble in water.
3. pH (of a 5.0% w/v Solution) 6.5 – 7.5
4. Loss on Drying (at 105°C for 3 hrs) NMT 8.0% w/w
5. Assay of Iron (on As is basis ) NLT 30.0% w/w
6. Bulk Density

· Untapped Density

· Tapped Density


0.65-0.75 gm/cc

0.75-0.85 gm/cc

7. Compressibility Index NMT11.0%
8. Particle size NLT 90% w/w passes through 22#

NMT 10% w/w passes through 80 #

Category Description
Pharmaceutical Drug Only Pharmaceutical usage.
Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial

Abstract Background: Iron Deficiency Anemia (IDA) is a major public health problem worldwide. Iron Bisglycinate Chelate (FeBC) and polymaltose iron (FeP) are used for the treatment of IDA and exhibit good tolerability with a low incidence of adverse effects. However,...

Read more
Trial Assessing the Efficacy of Iron Bisglycinate Chelate and Polymaltose Iron

Summary: Iron Deficiency Anemia (IDA) is a prevalent global health issue. Two commonly used treatments for IDA are Iron Bisglycinate Chelate (FeBC) and polymaltose iron (FeP). These treatments are well-tolerated by patients and have a low occurrence of adverse effects....

Read more
Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience

Abstract The following review of iron(III)-hydroxide polymaltose complex (IPC, Maltofer) shows that iron is significantly bioavailable after oral administration, especially in iron-deficient subjects. Numerous clinical trials in men, women, children and infants have shown that IPC is effective in treating...

Read more
Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: a systematic review and meta-analysis

Abstract Background: Iron deficiency anemia (IDA) is commonly treated with iron formulations. Despite the expanding acceptance of iron polymaltose complex (IPC) among clinicians, there is sparse and contradictory evidence regarding its efficacy in the management of IDA in children. This...

Read more
Download Brochure
Contact Us